Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have distinct clinical and hormonal differences, requiring thorough evaluation for proper diagnosis and management.

Improved care and timely diagnosis are needed for women with PCOD and PCOS, and CystaCare can help.

Skin issues can signal substance use, helping early detection and treatment.

Quetiapine may cause hair loss.

Spironolactone nano-formulations show promise for treating skin disorders, but more research is needed for safety and effectiveness.

Alopecia is a condition causing hair loss that can impact looks and mental health.

Three siblings with a rare genetic condition had abnormal sexual development and chose different gender identities, needing surgery and therapy.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Frontal fibrosing alopecia and ulerythema ophryogenes may be related and can evolve from one to the other.

Up to half of adult women may experience hair loss, and doctors should use medical history, exams, and tests to find the cause and treat it.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Male children's genital development issues can be caused by genetic mutations or environmental factors affecting hormone action.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

Scalp biopsies are essential for accurately diagnosing alopecia areata.

Spironolactone improved cognitive performance and early sleep quality but not manic symptoms, appetite, or body weight in bipolar disorder when added to sodium valproate.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Melatonin may improve some hormonal and inflammatory issues in women with PCOS.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

The document emphasizes the importance of correctly identifying and classifying genetic hair disorders to help diagnose related health conditions.

Transgender youth have more sleep disorders, but gender-affirming therapy may help reduce them.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Finasteride helps treat skin issues like acne and baldness by blocking testosterone conversion.